Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Kern H et al. Stimulation of monocytes and platelets by short-chain phosphatidylcholines with and without terminal carboxyl group. 1998 Biochim. Biophys. Acta pmid:9767093
Bozza PT et al. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. 1998 J. Leukoc. Biol. pmid:9766638
Marriott I et al. Differential kinetics for induction of interleukin-6 mRNA expression in murine peritoneal macrophages: evidence for calcium-dependent and independent-signalling pathways. 1998 J. Cell. Physiol. pmid:9766520
Kabasakal C et al. The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis. 1998 Jul-Sep Turk. J. Pediatr. pmid:9763906
Spoelstra FM et al. Effect of theophylline on CD11b and L-selectin expression and density of eosinophils and neutrophils in vitro. 1998 Eur. Respir. J. pmid:9762784
Tamm M et al. Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9761763
Kinn JW and Bache RJ Effect of platelet activation on coronary collateral blood flow. 1998 Circulation pmid:9760298
El-Shazly A et al. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils. 1998 Int. Arch. Allergy Immunol. pmid:9758899
Matsumoto K et al. Altered expression of CD11b and CD62L after cross-linking of CD45 isoforms on human eosinophils. 1998 Int. Arch. Allergy Immunol. pmid:9758894
El-Shazly A et al. Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate. 1998 Int. Arch. Allergy Immunol. pmid:9758889
Heath MF et al. Dextran-70 inhibits equine platelet aggregation induced by PAF but not by other agonists. 1998 Equine Vet. J. pmid:9758098
Endo S et al. Administration of methylprednisolone acetate into the subdural cavity in an infant with subdural fluid collection. PAF is a good indicator of the efficacy of the treatment. 1998 Childs Nerv Syst pmid:9753399
Rocha MF et al. Intestinal secretory factor released by macrophages stimulated with Clostridium difficile toxin A: role of interleukin 1beta. 1998 Infect. Immun. pmid:9746596
Huang Q et al. Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles. 1998 Am. J. Physiol. pmid:9746460
Kruse-Elliott KT et al. Low molecular weight heparin alters porcine neutrophil responses to platelet-activating factor. 1998 Shock pmid:9744648
Liu L et al. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator. 1998 J. Immunol. pmid:9743372
Cheryk LA et al. Alterations in blood platelet morphology during aggregate formation in the Asian elephant (Elephas maximus). 1998 J. Zoo Wildl. Med. pmid:9732033
M'Rabet L et al. Activation of the small GTPase rap1 in human neutrophils. 1998 Blood pmid:9731072
Burke-Gaffney A and Hellewell PG A CD18/ICAM-1-dependent pathway mediates eosinophil adhesion to human bronchial epithelial cells. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9730868
Ueno M et al. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen. 1998 Pharmacology pmid:9730778
Qu XW et al. Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats. 1998 J. Physiol. (Lond.) pmid:9729632
Ibe BO et al. Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal lamb. 1998 J. Appl. Physiol. pmid:9729586
Matsumoto K et al. Eosinophilic airway inflammation induced by repeated exposure to cigarette smoke. 1998 Eur. Respir. J. pmid:9727790
Rougier F and Denizot Y Platelet-activating factor and the growth of fibroblasts. 1998 Mol. Carcinog. pmid:9726813
Beyer AJ et al. PAF and CD18 mediate neutrophil infiltration in upper gastrointestinal tract during intra-abdominal sepsis. 1998 Am. J. Physiol. pmid:9724257
Mazer BD et al. Dose-dependent agonist and antagonist effects of the platelet-activating factor analogue 1-palmitoyl-2-acetoyl-sn-glycero-3-phosphocholine on B lymphocytes. 1998 J. Allergy Clin. Immunol. pmid:9723666
Karzai W et al. [Current aspects of immunomodulatory therapy initiation for sepsis]. 1998 Dtsch. Med. Wochenschr. pmid:9721572
Tsai IL et al. Anti-platelet aggregation constituents from Formosan Toddalia asiatica. 1998 Phytochemistry pmid:9720317
Tamaoki J et al. A human bronchial epithelial cell line releases arginine vasopressin: involvement of Ca2+ -activated K+ channels. 1998 Regul. Pept. pmid:9712168
Hilliquin P et al. A double blind, placebo controlled study of a platelet activating factor antagonist in patients with rheumatoid arthritis. 1998 J. Rheumatol. pmid:9712091
Pei Y et al. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. 1998 J. Immunol. pmid:9712066
Pérez-Arellano JL et al. BN 52021 (a platelet activating factor-receptor antagonist) decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis. 1998 Mediators Inflamm. pmid:9705608
Boulay F et al. Phagocyte chemoattractant receptors. 1997 Ann. N. Y. Acad. Sci. pmid:9704038
Thakur A and Willcox MD Cytokine and lipid inflammatory mediator profile of human tears during contact lens associated inflammatory diseases. 1998 Exp. Eye Res. pmid:9702174
Akisü M et al. Platelet-activating factor levels in term and preterm human milk. 1998 Biol. Neonate pmid:9701651
Pennings HJ et al. Tumour necrosis factor-alpha induces hyperreactivity in tracheal smooth muscle of the guinea-pig in vitro. 1998 Eur. Respir. J. pmid:9701413
Andersson R et al. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats. 1998 Pancreas pmid:9700940
Koyama S et al. Human lung fibroblasts release chemokinetic activity for monocytes constitutively. 1998 Am. J. Physiol. pmid:9700081
Alves AC et al. Effect of selective phosphodiesterase inhibitors on the rat eosinophil chemotactic response in vitro. 1997 Mem. Inst. Oswaldo Cruz pmid:9698934
DeCoster MA et al. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons. 1998 J. Neurosci. Res. pmid:9698157
Cruzado JM et al. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model. 1998 Clin. Exp. Immunol. pmid:9697996
Eakes AT and Olson MS Regulation of endothelin synthesis in hepatic endothelial cells. 1998 Am. J. Physiol. pmid:9696707
Karlsson H et al. Heparin ameliorates pulmonary hypertension induced by platelet-activating factor in pigs. 1998 Thromb. Res. pmid:9694244
Napoli C Familial hypercholesterolaemia and platelet-activating factor acetylhydrolase: difference between the homozygous and heterozygous form. 1998 Eur. J. Clin. Invest. pmid:9693945
Moro F et al. The beta and gamma subunits of the human platelet-activating factor acetyl hydrolase isoform Ib (PAFAH1B2 and PAFAH1B3) map to chromosome 11q23 and 19q13.1, respectively. 1998 Genomics pmid:9693049
Li HP et al. Effect of chinonin on acute hypoxic pulmonary vasoconstriction in Sprague-Dawley rats. 1998 Respirology pmid:9692515
Kaminskaia GO et al. [Features of oxidative metabolism and level of platelet activating factor in pulmonary and circulating phagocytes of tuberculosis-resistant animals at stages of experimental infection]. 1998 Probl Tuberk pmid:9691697
Ribaldi E et al. PAF levels in saliva are regulated by inflammatory cells. 1998 J. Periodont. Res. pmid:9689619
Stolarek R et al. Effect of various agonists on nitric oxide generation by human polymorphonuclear leukocytes. 1998 Int. J. Clin. Lab. Res. pmid:9689552
Gozal D et al. Platelet-activating factor modulates cardiorespiratory responses in the conscious rat. 1998 Am. J. Physiol. pmid:9688699
Bussolati B et al. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis. 1998 J. Immunol. pmid:9686616
da Silva MB et al. Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves. 1998 Vet. Res. Commun. pmid:9686442
Peçanha EP et al. Synthesis and pharmacological evaluation of a new class of bicyclic phospholipids, designed as platelet activating factor antagonists. 1998 Farmaco pmid:9679282
Barber LA et al. Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. 1998 J. Biol. Chem. pmid:9668065
Tuder RM and Voelkel NF Pulmonary hypertension and inflammation. 1998 J. Lab. Clin. Med. pmid:9665367
Manya H et al. Switching of platelet-activating factor acetylhydrolase catalytic subunits in developing rat brain. 1998 J. Biol. Chem. pmid:9660828
Akisü M et al. Effect of dietary n-3 fatty acids on hypoxia-induced necrotizing enterocolitis in young mice. n-3 fatty acids alter platelet-activating factor and leukotriene B4 production in the intestine. 1998 Biol. Neonate pmid:9657667
Ahmed A et al. Localization, quantification, and activation of platelet-activating factor receptor in human endometrium during the menstrual cycle: PAF stimulates NO, VEGF, and FAKpp125. 1998 FASEB J. pmid:9657523
Rainger GE et al. Neutrophils rolling on immobilised platelets migrate into homotypic aggregates after activation. 1998 Thromb. Haemost. pmid:9657445
Schwartz JD et al. Cardiopulmonary bypass primes polymorphonuclear leukocytes. 1998 J. Surg. Res. pmid:9655092
Loucks EB et al. Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia-reperfusion injury. 1997 Nov-Dec J Invest Surg pmid:9654389
Itadani K et al. Inhibition of Na+,K(+)-ATPase by platelet-activating factor in dog submandibular glands. 1998 Prostaglandins Other Lipid Mediat. pmid:9653774
Ginkgo biloba for dementia. 1998 Med Lett Drugs Ther pmid:9653424
Küçükhüseyin C et al. On the mechanisms of adenosine induced pulmonary vasoconstriction in rats. 1997 J Basic Clin Physiol Pharmacol pmid:9651801
Roudebush WE and Mathur RS Presence of platelet-activating factor in squirrel monkey (Saimiri boliviensis) spermatozoa: seasonal differences. 1998 Am. J. Primatol. pmid:9651652
Perry SW et al. Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis. 1998 J. Biol. Chem. pmid:9651362
Minamiya Y et al. Platelet-activating factor mediates intercellular adhesion molecule-1-dependent radical production in the nonhypoxic ischemia rat lung. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9651191
Han BH et al. In vitro platelet-activating factor receptor binding inhibitory activity of pinusolide derivatives: a structure-activity study. 1998 J. Med. Chem. pmid:9651167
Shindo K et al. Platelet-activating factor increases leukotriene B4 release in stimulated alveolar macrophages from asthmatic patients. 1998 Eur. Respir. J. pmid:9648962
Matsumoto K et al. Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase-dependent pathway. 1998 J. Allergy Clin. Immunol. pmid:9648711
Watson F and Edwards SW Stimulation of primed neutrophils by soluble immune complexes: priming leads to enhanced intracellular Ca2+ elevations, activation of phospholipase D, and activation of the NADPH oxidase. 1998 Biochem. Biophys. Res. Commun. pmid:9647777
Qayumi AK et al. The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury. 1998 Ann. Thorac. Surg. pmid:9647083
Shouji K et al. Platelet-activating factor is a key mediator of pulmonary vasoconstriction and bronchoconstriction after antigen challenge in the perfused sensitized rabbit lung. 1998 Shock pmid:9645492
Derewenda ZS and Derewenda U The structure and function of platelet-activating factor acetylhydrolases. 1998 Cell. Mol. Life Sci. pmid:9645224
Jung KY et al. Magnone A and B, novel anti-PAF tetrahydrofuran lignans from the flower buds of Magnolia fargesii. 1998 J. Nat. Prod. pmid:9644071
Botitsi E et al. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells. 1998 J. Lipid Res. pmid:9643362
Mackness B et al. Lack of protection against oxidative modification of LDL by avian HDL. 1998 Biochem. Biophys. Res. Commun. pmid:9642147
Izuoka T et al. Role of platelet-activating factor on extravascular lung water after coronary reperfusion in dogs. 1998 Jpn. J. Physiol. pmid:9639551
Grassi S et al. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei. 1998 J. Neurophysiol. pmid:9636125
Beck-Speier I et al. Pro-inflammatory response of alveolar macrophages induced by sulphite: studies with lucigenin-dependent chemiluminescence. 1998 Mar-Apr J. Biolumin. Chemilumin. pmid:9633012
Baker RR and Chang H MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities. 1998 Biochim. Biophys. Acta pmid:9630721
De Plaen IG et al. Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor. 1998 Biochim. Biophys. Acta pmid:9630621
Spapen H et al. The platelet-activating factor antagonist BB-882 does not improve tissue oxygen extraction in endotoxic shock. 1998 J Crit Care pmid:9627275
Takada Y et al. Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation. 1998 Surgery pmid:9626320
Werr J et al. beta1 integrins are critically involved in neutrophil locomotion in extravascular tissue In vivo. 1998 J. Exp. Med. pmid:9625769
Gómez FP et al. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma. 1998 Eur. Respir. J. pmid:9623685
Isumi H et al. Expression of a 45K subunit of platelet-activating factor acetylhydrolase in the developing mouse cerebellum. 1998 Anat. Embryol. pmid:9623676
Lapchyns'ka II [Platelet activating factor and its role in the pathogenesis of immune glomerulopathy]. 1998 Jan-Feb Lik. Sprava pmid:9621619
Lou YP et al. Platelet-activating factor induces goblet cell hyperplasia and mucin gene expression in airways. 1998 Am. J. Respir. Crit. Care Med. pmid:9620929
Mollinedo F et al. Physiological activation of human neutrophils down-regulates CD53 cell surface antigen. 1998 J. Leukoc. Biol. pmid:9620662
Shimada A et al. In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes. 1998 J. Invest. Dermatol. pmid:9620295
Tsuji F and Shirasawa E The role of platelet-activating factor in cell infiltration in endotoxin-induced uveitis in guinea pigs. 1998 Curr. Eye Res. pmid:9617545
Nakos G et al. Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components. 1998 Intensive Care Med pmid:9609406
Nguyen P et al. [Modulators of leukocytic functions]. 1998 J Mal Vasc pmid:9608925
ZaÄ­tseva LG et al. [The role of platelet activating factor in regulation of the phagocytic function of macrophages from different organs]. 1998 Biull Eksp Biol Med pmid:9606554
Kotelevets L et al. Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3'-kinase is a critical mediator of tumor invasion. 1998 J. Biol. Chem. pmid:9603913
O'Neill C Autocrine mediators are required to act on the embryo by the 2-cell stage to promote normal development and survival of mouse preimplantation embryos in vitro. 1998 Biol. Reprod. pmid:9603268
Gómez FP et al. The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma. 1998 Am. J. Respir. Crit. Care Med. pmid:9603138
László F and Whittle BJ Role of nitric oxide and platelet-activating factor in the initiation of indomethacin-provoked intestinal inflammation in rats. 1998 Eur. J. Pharmacol. pmid:9600654
Giménez R and Aguilar J Effects of CDP-choline administration on brain striatum platelet-activating factor in aging rats. 1998 Eur. J. Pharmacol. pmid:9600649